 | • レポートコード：QFJ1-3832 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗核抗体検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISA、間接蛍光抗体法、マルチプレックス試験）、用途別市場規模（全身性エリテマトーデス、シェーグレン症候群、関節リウマチ、強皮症、多発性筋炎、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗核抗体検査の市場動向 ・企業の競争状況、市場シェア ・抗核抗体検査の種類別市場規模と予測2016-2027（ELISA、間接蛍光抗体法、マルチプレックス試験） ・抗核抗体検査の用途別市場規模と予測2016-2027（全身性エリテマトーデス、シェーグレン症候群、関節リウマチ、強皮症、多発性筋炎、その他） ・抗核抗体検査の北米市場規模2016-2027（アメリカ、カナダ） ・抗核抗体検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗核抗体検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗核抗体検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗核抗体検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Abbott、Bio-Rad Laboratories、Trinity Biotech Ireland、Erba Diagnostics、Antibodies Incorporated、PerkinElmer、Immuno Concepts、Inova Diagnostics、ZEUS Scientific） ・結論 |
Antinuclear antibodies (ANA) are a group of autoantibodies produced by a person’s immune system when it fails to adequately distinguish between “self” and “nonself.” The ANA test detects these autoantibodies in the blood.
Market Analysis and Insights: Global Anti-Nuclear Antibody Test Market
The global Anti-Nuclear Antibody Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Nuclear Antibody Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Nuclear Antibody Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Nuclear Antibody Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Nuclear Antibody Test market.
Global Anti-Nuclear Antibody Test Scope and Market Size
Anti-Nuclear Antibody Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Nuclear Antibody Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
ELISA
Indirect Immunofluorescence
Multiplex Testing
Segment by Application
Systemic Lupus Erythematosus
Sjogren’s Syndrome
Rheumatoid Arthritis
Scleroderma
Polymyositis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Abbott
Bio-Rad Laboratories
Trinity Biotech Ireland
Erba Diagnostics
Antibodies Incorporated
PerkinElmer
Immuno Concepts
Inova Diagnostics
ZEUS Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Nuclear Antibody Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ELISA
1.2.3 Indirect Immunofluorescence
1.2.4 Multiplex Testing
1.3 Market by Application
1.3.1 Global Anti-Nuclear Antibody Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Systemic Lupus Erythematosus
1.3.3 Sjogren’s Syndrome
1.3.4 Rheumatoid Arthritis
1.3.5 Scleroderma
1.3.6 Polymyositis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Nuclear Antibody Test Market Perspective (2016-2027)
2.2 Anti-Nuclear Antibody Test Growth Trends by Regions
2.2.1 Anti-Nuclear Antibody Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Nuclear Antibody Test Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Nuclear Antibody Test Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Nuclear Antibody Test Industry Dynamic
2.3.1 Anti-Nuclear Antibody Test Market Trends
2.3.2 Anti-Nuclear Antibody Test Market Drivers
2.3.3 Anti-Nuclear Antibody Test Market Challenges
2.3.4 Anti-Nuclear Antibody Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Nuclear Antibody Test Players by Revenue
3.1.1 Global Top Anti-Nuclear Antibody Test Players by Revenue (2016-2021)
3.1.2 Global Anti-Nuclear Antibody Test Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Nuclear Antibody Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Nuclear Antibody Test Revenue
3.4 Global Anti-Nuclear Antibody Test Market Concentration Ratio
3.4.1 Global Anti-Nuclear Antibody Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Nuclear Antibody Test Revenue in 2020
3.5 Anti-Nuclear Antibody Test Key Players Head office and Area Served
3.6 Key Players Anti-Nuclear Antibody Test Product Solution and Service
3.7 Date of Enter into Anti-Nuclear Antibody Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Nuclear Antibody Test Breakdown Data by Type
4.1 Global Anti-Nuclear Antibody Test Historic Market Size by Type (2016-2021)
4.2 Global Anti-Nuclear Antibody Test Forecasted Market Size by Type (2022-2027)
5 Anti-Nuclear Antibody Test Breakdown Data by Application
5.1 Global Anti-Nuclear Antibody Test Historic Market Size by Application (2016-2021)
5.2 Global Anti-Nuclear Antibody Test Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-Nuclear Antibody Test Market Size (2016-2027)
6.2 North America Anti-Nuclear Antibody Test Market Size by Type
6.2.1 North America Anti-Nuclear Antibody Test Market Size by Type (2016-2021)
6.2.2 North America Anti-Nuclear Antibody Test Market Size by Type (2022-2027)
6.2.3 North America Anti-Nuclear Antibody Test Market Size by Type (2016-2027)
6.3 North America Anti-Nuclear Antibody Test Market Size by Application
6.3.1 North America Anti-Nuclear Antibody Test Market Size by Application (2016-2021)
6.3.2 North America Anti-Nuclear Antibody Test Market Size by Application (2022-2027)
6.3.3 North America Anti-Nuclear Antibody Test Market Size by Application (2016-2027)
6.4 North America Anti-Nuclear Antibody Test Market Size by Country
6.4.1 North America Anti-Nuclear Antibody Test Market Size by Country (2016-2021)
6.4.2 North America Anti-Nuclear Antibody Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Nuclear Antibody Test Market Size (2016-2027)
7.2 Europe Anti-Nuclear Antibody Test Market Size by Type
7.2.1 Europe Anti-Nuclear Antibody Test Market Size by Type (2016-2021)
7.2.2 Europe Anti-Nuclear Antibody Test Market Size by Type (2022-2027)
7.2.3 Europe Anti-Nuclear Antibody Test Market Size by Type (2016-2027)
7.3 Europe Anti-Nuclear Antibody Test Market Size by Application
7.3.1 Europe Anti-Nuclear Antibody Test Market Size by Application (2016-2021)
7.3.2 Europe Anti-Nuclear Antibody Test Market Size by Application (2022-2027)
7.3.3 Europe Anti-Nuclear Antibody Test Market Size by Application (2016-2027)
7.4 Europe Anti-Nuclear Antibody Test Market Size by Country
7.4.1 Europe Anti-Nuclear Antibody Test Market Size by Country (2016-2021)
7.4.2 Europe Anti-Nuclear Antibody Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Nuclear Antibody Test Market Size (2016-2027)
8.2 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Type
8.2.1 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Application
8.3.1 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Region
8.4.1 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Nuclear Antibody Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Nuclear Antibody Test Market Size (2016-2027)
9.2 Latin America Anti-Nuclear Antibody Test Market Size by Type
9.2.1 Latin America Anti-Nuclear Antibody Test Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Nuclear Antibody Test Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Nuclear Antibody Test Market Size by Type (2016-2027)
9.3 Latin America Anti-Nuclear Antibody Test Market Size by Application
9.3.1 Latin America Anti-Nuclear Antibody Test Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Nuclear Antibody Test Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Nuclear Antibody Test Market Size by Application (2016-2027)
9.4 Latin America Anti-Nuclear Antibody Test Market Size by Country
9.4.1 Latin America Anti-Nuclear Antibody Test Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Nuclear Antibody Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Nuclear Antibody Test Market Size (2016-2027)
10.2 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Type
10.2.1 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Application
10.3.1 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Country
10.4.1 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Nuclear Antibody Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Anti-Nuclear Antibody Test Introduction
11.1.4 Thermo Fisher Scientific Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Anti-Nuclear Antibody Test Introduction
11.2.4 Abbott Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Anti-Nuclear Antibody Test Introduction
11.3.4 Bio-Rad Laboratories Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Trinity Biotech Ireland
11.4.1 Trinity Biotech Ireland Company Details
11.4.2 Trinity Biotech Ireland Business Overview
11.4.3 Trinity Biotech Ireland Anti-Nuclear Antibody Test Introduction
11.4.4 Trinity Biotech Ireland Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.4.5 Trinity Biotech Ireland Recent Development
11.5 Erba Diagnostics
11.5.1 Erba Diagnostics Company Details
11.5.2 Erba Diagnostics Business Overview
11.5.3 Erba Diagnostics Anti-Nuclear Antibody Test Introduction
11.5.4 Erba Diagnostics Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.5.5 Erba Diagnostics Recent Development
11.6 Antibodies Incorporated
11.6.1 Antibodies Incorporated Company Details
11.6.2 Antibodies Incorporated Business Overview
11.6.3 Antibodies Incorporated Anti-Nuclear Antibody Test Introduction
11.6.4 Antibodies Incorporated Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.6.5 Antibodies Incorporated Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Details
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Anti-Nuclear Antibody Test Introduction
11.7.4 PerkinElmer Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.7.5 PerkinElmer Recent Development
11.8 Immuno Concepts
11.8.1 Immuno Concepts Company Details
11.8.2 Immuno Concepts Business Overview
11.8.3 Immuno Concepts Anti-Nuclear Antibody Test Introduction
11.8.4 Immuno Concepts Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.8.5 Immuno Concepts Recent Development
11.9 Inova Diagnostics
11.9.1 Inova Diagnostics Company Details
11.9.2 Inova Diagnostics Business Overview
11.9.3 Inova Diagnostics Anti-Nuclear Antibody Test Introduction
11.9.4 Inova Diagnostics Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.9.5 Inova Diagnostics Recent Development
11.10 ZEUS Scientific
11.10.1 ZEUS Scientific Company Details
11.10.2 ZEUS Scientific Business Overview
11.10.3 ZEUS Scientific Anti-Nuclear Antibody Test Introduction
11.10.4 ZEUS Scientific Revenue in Anti-Nuclear Antibody Test Business (2016-2021)
11.10.5 ZEUS Scientific Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-Nuclear Antibody Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ELISA
Table 3. Key Players of Indirect Immunofluorescence
Table 4. Key Players of Multiplex Testing
Table 5. Global Anti-Nuclear Antibody Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-Nuclear Antibody Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-Nuclear Antibody Test Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-Nuclear Antibody Test Market Share by Regions (2016-2021)
Table 9. Global Anti-Nuclear Antibody Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-Nuclear Antibody Test Market Share by Regions (2022-2027)
Table 11. Anti-Nuclear Antibody Test Market Trends
Table 12. Anti-Nuclear Antibody Test Market Drivers
Table 13. Anti-Nuclear Antibody Test Market Challenges
Table 14. Anti-Nuclear Antibody Test Market Restraints
Table 15. Global Anti-Nuclear Antibody Test Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-Nuclear Antibody Test Market Share by Players (2016-2021)
Table 17. Global Top Anti-Nuclear Antibody Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Nuclear Antibody Test as of 2020)
Table 18. Ranking of Global Top Anti-Nuclear Antibody Test Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-Nuclear Antibody Test Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-Nuclear Antibody Test Product Solution and Service
Table 22. Date of Enter into Anti-Nuclear Antibody Test Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Nuclear Antibody Test Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-Nuclear Antibody Test Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-Nuclear Antibody Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-Nuclear Antibody Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-Nuclear Antibody Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-Nuclear Antibody Test Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-Nuclear Antibody Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-Nuclear Antibody Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-Nuclear Antibody Test Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-Nuclear Antibody Test Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-Nuclear Antibody Test Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-Nuclear Antibody Test Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-Nuclear Antibody Test Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-Nuclear Antibody Test Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-Nuclear Antibody Test Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-Nuclear Antibody Test Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-Nuclear Antibody Test Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-Nuclear Antibody Test Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-Nuclear Antibody Test Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-Nuclear Antibody Test Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-Nuclear Antibody Test Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-Nuclear Antibody Test Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-Nuclear Antibody Test Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-Nuclear Antibody Test Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-Nuclear Antibody Test Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-Nuclear Antibody Test Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-Nuclear Antibody Test Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-Nuclear Antibody Test Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-Nuclear Antibody Test Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-Nuclear Antibody Test Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-Nuclear Antibody Test Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-Nuclear Antibody Test Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-Nuclear Antibody Test Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-Nuclear Antibody Test Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-Nuclear Antibody Test Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-Nuclear Antibody Test Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-Nuclear Antibody Test Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-Nuclear Antibody Test Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Anti-Nuclear Antibody Test Product
Table 65. Thermo Fisher Scientific Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Anti-Nuclear Antibody Test Product
Table 70. Abbott Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Bio-Rad Laboratories Company Details
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Anti-Nuclear Antibody Test Product
Table 75. Bio-Rad Laboratories Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 76. Bio-Rad Laboratories Recent Development
Table 77. Trinity Biotech Ireland Company Details
Table 78. Trinity Biotech Ireland Business Overview
Table 79. Trinity Biotech Ireland Anti-Nuclear Antibody Test Product
Table 80. Trinity Biotech Ireland Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 81. Trinity Biotech Ireland Recent Development
Table 82. Erba Diagnostics Company Details
Table 83. Erba Diagnostics Business Overview
Table 84. Erba Diagnostics Anti-Nuclear Antibody Test Product
Table 85. Erba Diagnostics Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 86. Erba Diagnostics Recent Development
Table 87. Antibodies Incorporated Company Details
Table 88. Antibodies Incorporated Business Overview
Table 89. Antibodies Incorporated Anti-Nuclear Antibody Test Product
Table 90. Antibodies Incorporated Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 91. Antibodies Incorporated Recent Development
Table 92. PerkinElmer Company Details
Table 93. PerkinElmer Business Overview
Table 94. PerkinElmer Anti-Nuclear Antibody Test Product
Table 95. PerkinElmer Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 96. PerkinElmer Recent Development
Table 97. Immuno Concepts Company Details
Table 98. Immuno Concepts Business Overview
Table 99. Immuno Concepts Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 100. Immuno Concepts Recent Development
Table 101. Inova Diagnostics Company Details
Table 102. Inova Diagnostics Business Overview
Table 103. Inova Diagnostics Anti-Nuclear Antibody Test Product
Table 104. Inova Diagnostics Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 105. Inova Diagnostics Recent Development
Table 106. ZEUS Scientific Company Details
Table 107. ZEUS Scientific Business Overview
Table 108. ZEUS Scientific Anti-Nuclear Antibody Test Product
Table 109. ZEUS Scientific Revenue in Anti-Nuclear Antibody Test Business (2016-2021) & (US$ Million)
Table 110. ZEUS Scientific Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Nuclear Antibody Test Market Share by Type: 2020 VS 2027
Figure 2. ELISA Features
Figure 3. Indirect Immunofluorescence Features
Figure 4. Multiplex Testing Features
Figure 5. Global Anti-Nuclear Antibody Test Market Share by Application: 2020 VS 2027
Figure 6. Systemic Lupus Erythematosus Case Studies
Figure 7. Sjogren’s Syndrome Case Studies
Figure 8. Rheumatoid Arthritis Case Studies
Figure 9. Scleroderma Case Studies
Figure 10. Polymyositis Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-Nuclear Antibody Test Report Years Considered
Figure 13. Global Anti-Nuclear Antibody Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anti-Nuclear Antibody Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anti-Nuclear Antibody Test Market Share by Regions: 2020 VS 2027
Figure 16. Global Anti-Nuclear Antibody Test Market Share by Regions (2022-2027)
Figure 17. Global Anti-Nuclear Antibody Test Market Share by Players in 2020
Figure 18. Global Top Anti-Nuclear Antibody Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Nuclear Antibody Test as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anti-Nuclear Antibody Test Revenue in 2020
Figure 20. Global Anti-Nuclear Antibody Test Revenue Market Share by Type (2016-2021)
Figure 21. Global Anti-Nuclear Antibody Test Revenue Market Share by Type (2022-2027)
Figure 22. North America Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anti-Nuclear Antibody Test Market Share by Type (2016-2027)
Figure 24. North America Anti-Nuclear Antibody Test Market Share by Application (2016-2027)
Figure 25. North America Anti-Nuclear Antibody Test Market Share by Country (2016-2027)
Figure 26. United States Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anti-Nuclear Antibody Test Market Share by Type (2016-2027)
Figure 30. Europe Anti-Nuclear Antibody Test Market Share by Application (2016-2027)
Figure 31. Europe Anti-Nuclear Antibody Test Market Share by Country (2016-2027)
Figure 32. Germany Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anti-Nuclear Antibody Test Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anti-Nuclear Antibody Test Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anti-Nuclear Antibody Test Market Share by Region (2016-2027)
Figure 42. China Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anti-Nuclear Antibody Test Market Share by Type (2016-2027)
Figure 50. Latin America Anti-Nuclear Antibody Test Market Share by Application (2016-2027)
Figure 51. Latin America Anti-Nuclear Antibody Test Market Share by Country (2016-2027)
Figure 52. Mexico Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anti-Nuclear Antibody Test Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anti-Nuclear Antibody Test Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anti-Nuclear Antibody Test Market Share by Country (2016-2027)
Figure 58. Turkey Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anti-Nuclear Antibody Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 64. Trinity Biotech Ireland Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 65. Erba Diagnostics Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 66. Antibodies Incorporated Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 67. PerkinElmer Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 68. Immuno Concepts Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 69. Inova Diagnostics Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 70. ZEUS Scientific Revenue Growth Rate in Anti-Nuclear Antibody Test Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の抗ニューロフィラメントL抗体市場規模・現状・予測（2021年-2027年） Neurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon. Market Analysis and Insights: Global Anti Neurofilament L Antibody Market The …- 世界のウサギ抽出抗DPH5抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-DPH5 Antibody Produced In Rabbit Market The global Anti-DPH5 Antibody Produced In Rabbit market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界の全身性強皮症治療薬市場規模・現状・予測（2021年-2027年） Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs . It is characterized by the buildup of scar tissue (fibrosis) in the skin and other organs. The fibrosis is caused by the body's production of too much collagen, which normally strengthens and supports connecti…
- 世界の全身性強皮症治療市場規模・現状・予測（2021年-2027年） Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs . It is characterized by the buildup of scar tissue (fibrosis) in the skin and other organs. The fibrosis is caused by the body's production of too much collagen, which normally strengthens and supports connecti…
- 世界の関節リウマチ診断装置市場規模・現状・予測（2021年-2027年） Rheumatoid Arthritis Diagnostic Device is equipment for Rheumatoid Arthritis Diagnostic. The rising incidence of rheumatoid arthritis has prompted various healthcare organizations and governments to raise awareness about the condition and its treatment plans and diagnostic procedures. Also, in the m…